Altimmune(ALT)
Search documents
Altimmune(ALT) - 2020 Q4 - Earnings Call Transcript
2021-02-25 20:21
Altimmune, Inc (NASDAQ:ALT) Q4 2020 Earnings Conference Call February 25, 2021 8:30 AM ET Company Participants Stacey Jurchison – Senior Director of Investor Relations and Corporate Communications Vipin Garg – President and Chief Executive Officer Scot Roberts – Chief Scientific Officer Scott Harris – Chief Medical Officer Will Brown – Chief Financial Officer Conference Call Participants Seamus Fernandez – Guggenheim Kelechi Chikere – Jefferies Mayank Mamtani – B.Riley FBR Jonathan Wolleben – JMP Securities ...
Altimmune(ALT) - 2020 Q3 - Earnings Call Transcript
2020-11-10 18:20
Altimmune, Inc. (NASDAQ:ALT) Q3 2020 Earnings Conference Call November 10, 2020 8:30 AM ET Company Participants Stacey Jurchison - Investor Relations Vipin Garg - Chief Executive Officer Scot Roberts - Chief Scientific Officer Scott Harris - Chief Medical Officer Will Brown - Chief Financial Officer Conference Call Participants Yasmeen Rahimi - Piper Sandler Mayank Mamtani - B. Riley FBR Jon Wolleben - JMP Securities Operator Good morning and welcome to the Altimmune, Inc. Third Quarter 2020 Earnings Confe ...
Altimmune(ALT) - 2020 Q3 - Quarterly Report
2020-11-09 21:21
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32587 ALTIMMUNE, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 20-2726770 (State or Other Jurisdictio ...
Altimmune(ALT) - 2020 Q2 - Earnings Call Transcript
2020-08-12 15:54
Altimmune, Inc. (NASDAQ:ALT) Q2 2020 Earnings Conference Call August 12, 2020 8:30 AM ET Company Participants Monique Kosse - IR, LifeSci Advisors Vipin Garg - Chief Executive Officer Scot Roberts - Chief Scientific Officer Scott Harris - Chief Medical Officer Will Brown - Chief Financial Officer Conference Call Participants Yasmeen Rahimi - Piper Sandler Jonathan Wolleben - JMP Securities Operator Greetings and welcome to the Altimmune Inc. Second Quarter 2020 Earnings Call. At this time, all participants ...
Altimmune(ALT) - 2020 Q2 - Quarterly Report
2020-08-11 20:13
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.0001 per share ALT The NASDAQ Global Market FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commi ...
Altimmune(ALT) - 2020 Q1 - Earnings Call Transcript
2020-05-14 15:58
Altimmune, Inc. (NASDAQ:ALT) Q1 2020 Earnings Conference Call May 14, 2020 8:30 AM ET Company Participants Monique Kosse - IR, LifeSci Advisors Vipin Garg - CEO Will Brown - CFO Scot Roberts - Chief Scientific Officer Scott Harris - Chief Medical Officer Conference Call Participants Yasmeen Rahimi - ROTH Capital Partners Jim Molloy - Alliance Global Partners Operator Thank you for standing by. This is the conference operator. Welcome to the Altimmune Incorporated First Quarter 2020 Earnings Conference Call. ...